1.
Elsebaie H, Yassa WSM, Lasheen S, IbrahimIbrahim N. Efficacy, Safety and Cost Effectiveness of Metronomic Low Dose Versus Intermittent High Dose Capecitabine in Metastatic Breast Cancer. Open Access Maced J Med Sci [Internet]. 2021 Oct. 3 [cited 2024 Dec. 4];9(B):1048-53. Available from: https://oamjms.eu/index.php/mjms/article/view/7089